InsiderDB

Lobbying disclosures · Lobbying report

ABBV: third_quarter 2026 lobbying report

Issues regarding life sciences related matters. Issues regarding life sciences related matters.

Follow ABBV
Became public
Oct 18, 2026, 8:38 PM EDT
Event / period date
Not stated
Collected
Nov 9, 2026, 9:38 AM EST

Why this is connected

Exact legal-name match: AbbVie Inc. (https://www.sec.gov/Archives/edgar/data/1551152/).

Reported lobbying amounts

Income: $90,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/5c1dfd82-e07d-48b2-a42f-ed3963926d8a/","filing_uuid":"5c1dfd82-e07d-48b2-a42f-ed3963926d8a","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/5c1dfd82-e07d-48b2-a42f-ed3963926d8a/print/","filing_document_content_type":"text/html","income":"90000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Kendall Conger","dt_posted":"2026-10-18T20:38:40-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"121 Reynolda Village Way Ste. A","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Winston Salem","registrant_state":"NC","registrant_zip":"27106","registrant":{"id":401109039,"url":"https://lda.gov/api/v1/registrants/401109039/","house_registrant_id":56739,"name":"CHECKMATE GOVERNMENT RELATIONS","description":null,"address_1":"121 Reynolda Village Way Ste. A","address_2":null,"address_3":null,"address_4":null,"city":"Winston Salem","state":"NC","state_display":"North Carolina","zip":"27106","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KENDALL CONGER","contact_telephone":"+1 919-740-1863","dt_updated":"2026-10-13T06:24:23.250297-04:00"},"client":{"id":71148,"url":"https://lda.gov/api/v1/clients/71148/","client_id":71148,"name":"ABBVIE INC.","general_description":"Medical solution provider","client_government_entity":null,"client_self_select":false,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-01-21"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues regarding life sciences related matters.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":153373,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":"LUCAS","last_name":"BLANCHAT","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Congressman Richard Hudson; Deputy State Director, Senator Thom Tillis","new":false},{"lobbyist":{"id":148771,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"MCDOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149198,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"KOURY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149175,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"LACIVITA","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues regarding life sciences related matters.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148771,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"MCDOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149198,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"KOURY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149175,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"LACIVITA","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":153373,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":"LUCAS","last_name":"BLANCHAT","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Congressman Richard Hudson; Deputy State Director, Senator Thom Tillis","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Price change after we could observe it

+0.37% ABBV

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in ABBV

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.